Table 1.
Baseline demographics and clinical characteristics of study population
Variables | Patients (n=252) |
---|---|
Age, years | 46±8 |
Gender, male | 71% |
BMI, kg/m2 | 30.4±4.7 |
Waist circumference, cm | 101±11 |
Hypertension | 65% |
Diabetes mellitus | 8% |
Smoking status | 20% |
Dyslipidemia | 35% |
Family history of CAD | 45% |
Glucose, mg/dL | 103±31 |
Creatinine, mg/dL | 0.84±0.16 |
Uric acid, mg/dL | 5.3±1.5 |
T. Bilirubin, mg/dL | 0.81±0.45 |
Total cholesterol, mg/dL | 216±41 |
LDL-cholesterol, mg/dL | 136±36 |
HDL-cholesterol, mg/dL | 45±12 |
Triglycerides, mg/dL | 176±121 |
CRP, mg/dL, median/range | 0.32 (3.96) |
CRP, log-transformed | -0.46±0.33 |
ALT, U/L | 28±20 |
GGT activity, U/L | 32±22 |
Leukocytes, 103/mm3 | 7.6±1.8 |
Hemoglobin, g/dL | 14.5±1.5 |
Platelets, 103/mm3 | 280±64 |
CIMT, mm, mean | 0.81±0.17 |
Presence of carotid plaque | 18% |
EAT, mm | 5.8±2.5 |
ALT - alanine aminotransferase; BMI - body mass index; CAD - coronary artery disease; CIMT - carotid intima-media thickness; CRP - C-reactive protein; EAT - epicardial adipose tissue thickness; GGT - gamma-glutamyl transferase; HDL - high density lipoprotein; LDL - low density lipoprotein. Continuous variables were given as mean±SD; categorical variables were defined as percentages